Correlation Between Altimmune and Day One
Can any of the company-specific risk be diversified away by investing in both Altimmune and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Altimmune and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Altimmune and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Altimmune and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Altimmune with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Altimmune and Day One.
Diversification Opportunities for Altimmune and Day One
Very good diversification
The 3 months correlation between Altimmune and Day is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Altimmune and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Altimmune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Altimmune are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Altimmune i.e., Altimmune and Day One go up and down completely randomly.
Pair Corralation between Altimmune and Day One
Considering the 90-day investment horizon Altimmune is expected to generate 3.0 times more return on investment than Day One. However, Altimmune is 3.0 times more volatile than Day One Biopharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about -0.21 per unit of risk. If you would invest 868.00 in Altimmune on September 23, 2024 and sell it today you would lose (43.00) from holding Altimmune or give up 4.95% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Altimmune vs. Day One Biopharmaceuticals
Performance |
Timeline |
Altimmune |
Day One Biopharmaceu |
Altimmune and Day One Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Altimmune and Day One
The main advantage of trading using opposite Altimmune and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Altimmune position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.Altimmune vs. Reviva Pharmaceuticals Holdings | Altimmune vs. Athira Pharma | Altimmune vs. Fortress Biotech | Altimmune vs. ACADIA Pharmaceuticals |
Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |